ARTT Center of Excellence UT Health San Antonio




Behavior, Biology, and Chemistry:
Translational Research in Addiction

2020 BBC Program - Coming Soon!



FRIDAY 28 February 2020

SATURDAY 29 February 2020

  • BBC Registration
  • Welcome and Opening Remarks
  • Poster Session 1
  • Plenary Symposium: "Sex Differences in Addiction"
    • Cora Lee Wetherington, PhD, National Institute on Drug Abuse
      Sex as a Biological Variable in Addiction Research: Past, Present and Future and Why it Matters
    • Rebecca Craft, PhD, Washington State University
      Sex Differences in Behavioral Effects of Opioids and Cannabinoids
    • Suzette Evans, PhD, Columbia University
      Sex Differences in the Behavioral Responses to Drugs of Abuse: Translational Evidence from Human and Non-human Primate Laboratory Studies
    • Sherry McKee, PhD
      Considering Sex Differences in Treatment Development for Smoking
  • Oral Communications
  • Special Lecture: Roland R Griffiths, PhD, Johns Hopkins University
    • Psilocybin: History, Neuropharmacology, and Implications for Treatment of Drug Addiction and Other Psychiatric Disorders
  • Cocktail Hour and Poster Session
  • Hospitality and Entertainment

SUNDAY 1 MARCH 2020

  • Poster Session 2
  • Open Oral Communications
  • Special Lecture: Bruce E Blough, PhD, RTI
    • The Evolution of Releaser Stimulants from Natural Products to Bath Salts
  • Presentation of travel awards and awards for oral and poster presentations *
  • Adjournment and Lunch
*Attendees must be present when winners are announced at the closing remarks to accept prizes for oral and poster presentations. If the winner is not present, they forfeit their prizes.


Funding for this conference is made possible [in part] by R13 DA029347 from The National Institute on Drug Abuse (NIDA). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.